PRESS RELEASE: Medicinal cannabis – Joe Biden’s White House reviews Cannabis decriminalisation.

“No one should be jailed for using or possessing marijuana.” Joe Biden stated during his State of the Union address 2024.

US regulators are planning to announce the reclassification of cannabis which will effectively decriminalise cannabis for medicinal use in the United States, NBC reported today.

The re-classification from Schedule I to Schedule III will see medicinal cannabis regulated alongside products like Tylenol Aspirin, & Codeine.

Schedule 1 compounds are drugs which have no medicinal use along with significant potential for abuse.

Clearly not the situation with medicinal cannabis, which has been prized for its medical uses for over two thousand years.

The reclassification of medicinal cannabis will deliver other significant benefits including:-
– conventional pharmaceutical research could be conducted verifying medicinal cannabis’ efficacy,
– safe and secure and tested products will become more broadly and more conveniently available to patients.

Corollary benefits will include downward pressure on illicit and black markets, reducing the pressures on policing, judicial and regulatory authorities.

Commenting today, Tom Varga, Biortica’s CEO said , “This is great news. We’re not there yet but it seems that the US legislators are considering what could be a win across the board, a win for the legitimate cannabis industry, a win for regulators and most importantly a win for patients.”

“This US news together recent news from the EU is clear recognition that the world is moving from prohibition to recognition,” he said.

“We look forward to and will fully support any initiatives we can to build to establish an effective Australian regulatory framework.

Media Contacts:

Name: John Kochanski, CMOCompany: Biortica Agrimed LtdEmail: Phone: 0411831122

Attachments:

    About Biortica Agrimed Ltd

    View Website

    BIORTICA AGRIMED Award winning, Biortica Agrimed Ltd is Australia’s largest fully vertically integrated commercial grower of medicinal plants. Our B2B operations are seamlessly integrated from plant genetics through to supply of medicinal plants in commercial quantities. We employ glasshouse-based horticulture, to both, protect our valuable medicinal crops, and equally to minimise our environmental impact, thereby protecting the planet. Our goal is to significantly improve human health outcomes by supplying high quality agricultural medicinal plants, at scale, to uniform high quality standards year-round. CONTACT: Tom Varga, CEO, Biortica Agrimed e [email protected] m +61 (0)499 991 745